Interactors | Protein name | Directionality | Classification | |
|---|---|---|---|---|
| 1 | ALB-B2M+FCGRT | ALBU_HUMAN - | Ligand-Receptor | |
| 2 | APOA1-AMN+CUBN | APOA1_HUMAN - | Ligand-Receptor | Signaling by Apolipoprotein |
| 3 | APP-SORL1 | A4_HUMAN - SORL_HUMAN | Ligand-Receptor | Signaling by Amyloid-beta precursor protein |
| 4 | AREG-EGFR | AREG_HUMAN - EGFR_HUMAN | Ligand-Receptor | Signaling by Epidermal growth factor |
| 5 | BMP10-ACVRL1+BMPR2 | BMP10_HUMAN - | Ligand-Receptor | Signaling by BMP |
| 6 | BMP15-BMPR1B+BMPR2 | BMP15_HUMAN - | Ligand-Receptor | Signaling by BMP |
| 7 | BMP15+GDF2-ACVR1B+BMPR1B+BMPR2 | - | Ligand-Receptor | Signaling by BMP |
| 8 | BMP2-BMPR1A+BMPR2 | BMP2_HUMAN - | Ligand-Receptor | Signaling by BMP |
| 9 | BMP2-BMPR1B+BMPR2 | BMP2_HUMAN - | Ligand-Receptor | Signaling by BMP |
| 10 | BMP4-BMPR1A+BMPR2 | BMP4_HUMAN - | Ligand-Receptor | Signaling by BMP |
| 11 | BMP4-BMPR1B+BMPR2 | BMP4_HUMAN - | Ligand-Receptor | Signaling by BMP |
| 12 | BMP5-ACVR1+BMPR2 | BMP5_HUMAN - | Ligand-Receptor | Signaling by BMP |
| 13 | BMP5-BMPR1A+BMPR2 | BMP5_HUMAN - | Ligand-Receptor | Signaling by BMP |
| 14 | BMP5-BMPR1B+BMPR2 | BMP5_HUMAN - | Ligand-Receptor | Signaling by BMP |
| 15 | BMP6-ACVR1+BMPR2 | BMP6_HUMAN - | Ligand-Receptor | Signaling by BMP |
| 16 | BMP6-BMPR1A+BMPR2 | BMP6_HUMAN - | Ligand-Receptor | Signaling by BMP |
| 17 | BMP6-BMPR1B+BMPR2 | BMP6_HUMAN - | Ligand-Receptor | Signaling by BMP |
| 18 | BMP7-ACVR1+BMPR2 | BMP7_HUMAN - | Ligand-Receptor | Signaling by BMP |
| 19 | BMP7-BMPR1A+BMPR2 | BMP7_HUMAN - | Ligand-Receptor | Signaling by BMP |
| 20 | BMP7-BMPR1B+BMPR2 | BMP7_HUMAN - | Ligand-Receptor | Signaling by BMP |
| 21 | BMP8A-ACVR1+BMPR2 | BMP8A_HUMAN - | Ligand-Receptor | Signaling by BMP |
| 22 | BMP8A-BMPR1A+BMPR2 | BMP8A_HUMAN - | Ligand-Receptor | Signaling by BMP |
| 23 | BMP8A-BMPR1B+BMPR2 | BMP8A_HUMAN - | Ligand-Receptor | Signaling by BMP |
| 24 | BTC-EGFR | BTC_HUMAN - EGFR_HUMAN | Ligand-Receptor | Signaling by Epidermal growth factor |
| 25 | BTC-ERBB3 | BTC_HUMAN - ERBB3_HUMAN | Ligand-Receptor | Signaling by Betacellulin |
| 26 | C3-ITGAM+ITGB2 | CO3_HUMAN - | Ligand-Receptor | Signaling by Complement |
| 27 | CD1D-LILRB2 | CD1D_HUMAN - LIRB2_HUMAN | Ligand-Receptor | |
| 28 | CEACAM8-CEACAM6 | CEAM8_HUMAN - CEAM6_HUMAN | Adhesion-Adhesion | Adhesion by CEAM |
| 29 | CGA+CGB1-LHCGR | - LSHR_HUMAN | Ligand-Receptor | Signaling by Choriogonadotropin |
| 30 | CGA+CGB2-LHCGR | - LSHR_HUMAN | Ligand-Receptor | Signaling by Choriogonadotropin |
| 31 | CGA+CGB3-LHCGR | - LSHR_HUMAN | Ligand-Receptor | Signaling by Choriogonadotropin |
| 32 | CGA+CGB7-LHCGR | - LSHR_HUMAN | Ligand-Receptor | Signaling by Choriogonadotropin |
| 33 | CGA+LHB-LHCGR | - LSHR_HUMAN | Ligand-Receptor | Signaling by Choriogonadotropin |
| 34 | EGF-EGFR | EGF_HUMAN - EGFR_HUMAN | Ligand-Receptor | Signaling by Epidermal growth factor |
| 35 | EPGN-EGFR | EPGN_HUMAN - EGFR_HUMAN | Ligand-Receptor | Signaling by Epidermal growth factor |
| 36 | EREG-EGFR | EREG_HUMAN - EGFR_HUMAN | Ligand-Receptor | Signaling by Epidermal growth factor |
| 37 | F10-ITGAM+ITGB2 | FA10_HUMAN - | Ligand-Receptor | Adhesion by Prothrombin |
| 38 | F2-GP1BA+GP1BB | THRB_HUMAN - | Ligand-Receptor | Adhesion by Prothrombin |
| 39 | F2-THBD | THRB_HUMAN - TRBM_HUMAN | Ligand-Receptor | Adhesion by Prothrombin |
| 40 | FASLG-TNFRSF6B | TNFL6_HUMAN - TNF6B_HUMAN | Ligand-Receptor | Signaling by Tumor necrosis factor |
| 41 | FGA+FGB+FGG-ITGAM+ITGB2 | - | Ligand-Receptor | Adhesion by Fibribogen |
| 42 | GAS6-AXL | GAS6_HUMAN - UFO_HUMAN | Ligand-Receptor | Signaling by Growth arrest |
| 43 | GAS6-MERTK | GAS6_HUMAN - MERTK_HUMAN | Ligand-Receptor | Signaling by Growth arrest |
| 44 | GDF2-ACVRL1+BMPR2 | GDF2_HUMAN - | Ligand-Receptor | Signaling by Growth differentiation factor |
| 45 | GDF5-BMPR1B+BMPR2 | GDF5_HUMAN - | Ligand-Receptor | Signaling by Growth differentiation factor |
| 46 | GDF6-BMPR1A+BMPR2 | GDF6_HUMAN - | Ligand-Receptor | Signaling by Growth differentiation factor |
| 47 | GDF6-BMPR1B+BMPR2 | GDF6_HUMAN - | Ligand-Receptor | Signaling by Growth differentiation factor |
| 48 | GDF7-BMPR1A+BMPR2 | GDF7_HUMAN - | Ligand-Receptor | Signaling by Growth differentiation factor |
| 49 | GDF7-BMPR1B+BMPR2 | GDF7_HUMAN - | Ligand-Receptor | Signaling by Growth differentiation factor |
| 50 | GDF9-BMPR2+TGFBR1 | GDF9_HUMAN - | Ligand-Receptor | Signaling by Growth differentiation factor |
| 51 | GH1-GHR | SOMA_HUMAN - GHR_HUMAN | Ligand-Receptor | Signaling by Somatostatin |
| 52 | GH2-GHR | SOM2_HUMAN - GHR_HUMAN | Ligand-Receptor | Signaling by Somatostatin |
| 53 | GP1BA-ITGAM+ITGB2 | GP1BA_HUMAN - | Ligand-Receptor | |
| 54 | C10orf99-SUSD2 | GP15L_HUMAN - SUSD2_HUMAN | Ligand-Receptor | |
| 55 | HBEGF-EGFR | HBEGF_HUMAN - EGFR_HUMAN | Ligand-Receptor | Signaling by Epidermal growth factor |
| 56 | HFE-TFRC | HFE_HUMAN - TFR1_HUMAN | Ligand-Receptor | |
| 57 | ICAM1-ITGAM+ITGB2 | ICAM1_HUMAN - | Ligand-Receptor | Adhesion by ICAM |
| 58 | ICAM1-SPN | ICAM1_HUMAN - LEUK_HUMAN | Adhesion-Adhesion | Adhesion by ICAM |
| 59 | IL13-IL13RA2 | IL13_HUMAN - I13R2_HUMAN | Ligand-Receptor | Signaling by Interleukin |
| 60 | IL5-CSF2RB+IL5RA | IL5_HUMAN - | Ligand-Receptor | Signaling by Interleukin |
| 61 | IL9-IL2RG+IL9R | IL9_HUMAN - | Ligand-Receptor | Signaling by Interleukin |
| 62 | JAM3-ITGAM+ITGB2 | JAM3_HUMAN - | Adhesion-Adhesion | Adhesion by JAM |
| 63 | KITLG-KIT | SCF_HUMAN - KIT_HUMAN | Ligand-Receptor | |
| 64 | LGALS3-MERTK | LEG3_HUMAN - MERTK_HUMAN | Ligand-Receptor | Signaling by Galectin |
| 65 | LHB-LHCGR | LSHB_HUMAN - LSHR_HUMAN | Ligand-Receptor | |
| 66 | LTA-TNFRSF1A | TNFB_HUMAN - TNR1A_HUMAN | Ligand-Receptor | Signaling by Tumor necrosis factor |
| 67 | NRG1-ERBB3 | NRG1_HUMAN - ERBB3_HUMAN | Ligand-Receptor | Signaling by Neuregulin |
| 68 | NRG2-ERBB3 | NRG2_HUMAN - ERBB3_HUMAN | Ligand-Receptor | Signaling by Neuregulin |
| 69 | PGF-FLT1 | PLGF_HUMAN - VGFR1_HUMAN | Ligand-Receptor | Signaling by Placenta growth factor |
| 70 | PGF-FLT1+KDR | PLGF_HUMAN - | Ligand-Receptor | Signaling by Placenta growth factor |
| 71 | PGF-NRP1 | PLGF_HUMAN - NRP1_HUMAN | Ligand-Receptor | Signaling by Placenta growth factor |
| 72 | PODXL-SELL | PODXL_HUMAN - LYAM1_HUMAN | Receptor-Receptor | Signaling by Podocalyxin-like protein |
| 73 | PROC-PROCR | PROC_HUMAN - PROCR_HUMAN | Ligand-Receptor | |
| 74 | RELN-LRP8 | RELN_HUMAN - LRP8_HUMAN | Ligand-Receptor | Signaling by Reelin |
| 75 | SEMA3A-NRP1 | SEM3A_HUMAN - NRP1_HUMAN | Ligand-Receptor | Signaling by Semaphorin |
| 76 | SEMA3A-NRP1+PLXNA1 | SEM3A_HUMAN - | Ligand-Receptor | Signaling by Semaphorin |
| 77 | SEMA3A-NRP1+PLXNA2 | SEM3A_HUMAN - | Ligand-Receptor | Signaling by Semaphorin |
| 78 | SEMA3A-NRP1+PLXNA3 | SEM3A_HUMAN - | Ligand-Receptor | Signaling by Semaphorin |
| 79 | SEMA3A-NRP1+PLXNA4 | SEM3A_HUMAN - | Ligand-Receptor | Signaling by Semaphorin |
| 80 | TF-TFRC | TRFE_HUMAN - TFR1_HUMAN | Ligand-Receptor | Signaling by Transferrin |
| 81 | TGFA-EGFR | TGFA_HUMAN - EGFR_HUMAN | Ligand-Receptor | Signaling by Transforming growth factor |
| 82 | TGFB1-TGFBR3 | TGFB1_HUMAN - TGBR3_HUMAN | Ligand-Receptor | Signaling by Transforming growth factor |
| 83 | TGFB2-TGFBR3 | TGFB2_HUMAN - TGBR3_HUMAN | Ligand-Receptor | Signaling by Transforming growth factor |
| 84 | TGFB3-TGFBR3 | TGFB3_HUMAN - TGBR3_HUMAN | Ligand-Receptor | Signaling by Transforming growth factor |
| 85 | THBS1-CD36 | TSP1_HUMAN - CD36_HUMAN | Ligand-Receptor | Signaling by Thrombospondin precursor |
| 86 | TNF-TNFRSF1A | TNFA_HUMAN - TNR1A_HUMAN | Ligand-Receptor | Signaling by Tumor necrosis factor |
| 87 | TNFSF11-TNFRSF11B | TNF11_HUMAN - TR11B_HUMAN | Ligand-Receptor | Signaling by Tumor necrosis factor |
| 88 | TNFSF14-TNFRSF6B | TNF14_HUMAN - TNF6B_HUMAN | Ligand-Receptor | Signaling by Tumor necrosis factor |
| 89 | TNFSF15-TNFRSF6B | TNF15_HUMAN - TNF6B_HUMAN | Ligand-Receptor | Signaling by Tumor necrosis factor |
| 90 | VEGFA-FLT1 | VEGFA_HUMAN - VGFR1_HUMAN | Ligand-Receptor | Signaling by Vascular endothelial growth factor |
| 91 | VEGFA-FLT1+KDR | VEGFA_HUMAN - | Ligand-Receptor | Signaling by Vascular endothelial growth factor |
| 92 | VEGFA-NRP1 | VEGFA_HUMAN - NRP1_HUMAN | Ligand-Receptor | Signaling by Vascular endothelial growth factor |
| 93 | VEGFB-FLT1 | VEGFB_HUMAN - VGFR1_HUMAN | Ligand-Receptor | Signaling by Vascular endothelial growth factor |
| 94 | VEGFB-FLT1+KDR | VEGFB_HUMAN - | Ligand-Receptor | Signaling by Vascular endothelial growth factor |
| 95 | VEGFB-NRP1 | VEGFB_HUMAN - NRP1_HUMAN | Ligand-Receptor | Signaling by Vascular endothelial growth factor |
| 96 | VWF-GP1BA+GP1BB | VWF_HUMAN - | Ligand-Receptor | Signaling by von Willebrand factor |
| 97 | WNT1-CER1 | WNT1_HUMAN - CER1_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 98 | WNT1-FRZB | WNT1_HUMAN - SFRP3_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 99 | WNT1-SFRP1 | WNT1_HUMAN - SFRP1_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 100 | WNT1-SFRP2 | WNT1_HUMAN - SFRP2_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 101 | WNT1-SFRP4 | WNT1_HUMAN - SFRP4_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 102 | WNT1-SFRP5 | WNT1_HUMAN - SFRP5_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 103 | WNT10A-FRZB | WN10A_HUMAN - SFRP3_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 104 | WNT11-CER1 | WNT11_HUMAN - CER1_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 105 | WNT11-FRZB | WNT11_HUMAN - SFRP3_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 106 | WNT11-SFRP1 | WNT11_HUMAN - SFRP1_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 107 | WNT11-SFRP2 | WNT11_HUMAN - SFRP2_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 108 | WNT11-SFRP4 | WNT11_HUMAN - SFRP4_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 109 | WNT11-SFRP5 | WNT11_HUMAN - SFRP5_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 110 | WNT16-CER1 | WNT16_HUMAN - CER1_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 111 | WNT16-FRZB | WNT16_HUMAN - SFRP3_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 112 | WNT16-SFRP1 | WNT16_HUMAN - SFRP1_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 113 | WNT16-SFRP2 | WNT16_HUMAN - SFRP2_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 114 | WNT16-SFRP4 | WNT16_HUMAN - SFRP4_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 115 | WNT16-SFRP5 | WNT16_HUMAN - SFRP5_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 116 | WNT2-CER1 | WNT2_HUMAN - CER1_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 117 | WNT2-FRZB | WNT2_HUMAN - SFRP3_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 118 | WNT2-SFRP1 | WNT2_HUMAN - SFRP1_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 119 | WNT2-SFRP2 | WNT2_HUMAN - SFRP2_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 120 | WNT2-SFRP4 | WNT2_HUMAN - SFRP4_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 121 | WNT2-SFRP5 | WNT2_HUMAN - SFRP5_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 122 | WNT2B-CER1 | WNT2B_HUMAN - CER1_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 123 | WNT2B-FRZB | WNT2B_HUMAN - SFRP3_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 124 | WNT2B-SFRP1 | WNT2B_HUMAN - SFRP1_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 125 | WNT2B-SFRP2 | WNT2B_HUMAN - SFRP2_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 126 | WNT2B-SFRP4 | WNT2B_HUMAN - SFRP4_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 127 | WNT2B-SFRP5 | WNT2B_HUMAN - SFRP5_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 128 | WNT3-CER1 | WNT3_HUMAN - CER1_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 129 | WNT3-FRZB | WNT3_HUMAN - SFRP3_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 130 | WNT3-SFRP1 | WNT3_HUMAN - SFRP1_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 131 | WNT3-SFRP2 | WNT3_HUMAN - SFRP2_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 132 | WNT3-SFRP4 | WNT3_HUMAN - SFRP4_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 133 | WNT3-SFRP5 | WNT3_HUMAN - SFRP5_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 134 | WNT3A-CER1 | WNT3A_HUMAN - CER1_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 135 | WNT3A-FRZB | WNT3A_HUMAN - SFRP3_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 136 | WNT3A-SFRP1 | WNT3A_HUMAN - SFRP1_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 137 | WNT3A-SFRP2 | WNT3A_HUMAN - SFRP2_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 138 | WNT3A-SFRP4 | WNT3A_HUMAN - SFRP4_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 139 | WNT3A-SFRP5 | WNT3A_HUMAN - SFRP5_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 140 | WNT4-CER1 | WNT4_HUMAN - CER1_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 141 | WNT4-FRZB | WNT4_HUMAN - SFRP3_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 142 | WNT4-SFRP1 | WNT4_HUMAN - SFRP1_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 143 | WNT4-SFRP2 | WNT4_HUMAN - SFRP2_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 144 | WNT4-SFRP4 | WNT4_HUMAN - SFRP4_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 145 | WNT4-SFRP5 | WNT4_HUMAN - SFRP5_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 146 | WNT5A-CER1 | WNT5A_HUMAN - CER1_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 147 | WNT5A-FRZB | WNT5A_HUMAN - SFRP3_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 148 | WNT5A-SFRP1 | WNT5A_HUMAN - SFRP1_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 149 | WNT5A-SFRP2 | WNT5A_HUMAN - SFRP2_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 150 | WNT5A-SFRP4 | WNT5A_HUMAN - SFRP4_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 151 | WNT5A-SFRP5 | WNT5A_HUMAN - SFRP5_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 152 | WNT5B-CER1 | WNT5B_HUMAN - CER1_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 153 | WNT5B-FRZB | WNT5B_HUMAN - SFRP3_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 154 | WNT5B-SFRP1 | WNT5B_HUMAN - SFRP1_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 155 | WNT5B-SFRP2 | WNT5B_HUMAN - SFRP2_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 156 | WNT5B-SFRP4 | WNT5B_HUMAN - SFRP4_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 157 | WNT5B-SFRP5 | WNT5B_HUMAN - SFRP5_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 158 | WNT6-CER1 | WNT6_HUMAN - CER1_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 159 | WNT6-FRZB | WNT6_HUMAN - SFRP3_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 160 | WNT6-SFRP1 | WNT6_HUMAN - SFRP1_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 161 | WNT6-SFRP2 | WNT6_HUMAN - SFRP2_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 162 | WNT6-SFRP4 | WNT6_HUMAN - SFRP4_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 163 | WNT6-SFRP5 | WNT6_HUMAN - SFRP5_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 164 | WNT7A-CER1 | WNT7A_HUMAN - CER1_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 165 | WNT7A-FRZB | WNT7A_HUMAN - SFRP3_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 166 | WNT7A-SFRP1 | WNT7A_HUMAN - SFRP1_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 167 | WNT7A-SFRP2 | WNT7A_HUMAN - SFRP2_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 168 | WNT7A-SFRP4 | WNT7A_HUMAN - SFRP4_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 169 | WNT7A-SFRP5 | WNT7A_HUMAN - SFRP5_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 170 | WNT7B-CER1 | WNT7B_HUMAN - CER1_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 171 | WNT7B-FRZB | WNT7B_HUMAN - SFRP3_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 172 | WNT7B-SFRP1 | WNT7B_HUMAN - SFRP1_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 173 | WNT7B-SFRP2 | WNT7B_HUMAN - SFRP2_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 174 | WNT7B-SFRP4 | WNT7B_HUMAN - SFRP4_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 175 | WNT7B-SFRP5 | WNT7B_HUMAN - SFRP5_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 176 | WNT8A-CER1 | WNT8A_HUMAN - CER1_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 177 | WNT8A-FRZB | WNT8A_HUMAN - SFRP3_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 178 | WNT8A-SFRP1 | WNT8A_HUMAN - SFRP1_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 179 | WNT8A-SFRP2 | WNT8A_HUMAN - SFRP2_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 180 | WNT8A-SFRP4 | WNT8A_HUMAN - SFRP4_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 181 | WNT8A-SFRP5 | WNT8A_HUMAN - SFRP5_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 182 | WNT8B-CER1 | WNT8B_HUMAN - CER1_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 183 | WNT8B-FRZB | WNT8B_HUMAN - SFRP3_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 184 | WNT8B-SFRP1 | WNT8B_HUMAN - SFRP1_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 185 | WNT8B-SFRP2 | WNT8B_HUMAN - SFRP2_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 186 | WNT8B-SFRP4 | WNT8B_HUMAN - SFRP4_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 187 | WNT8B-SFRP5 | WNT8B_HUMAN - SFRP5_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 188 | WNT9A-CER1 | WNT9A_HUMAN - CER1_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 189 | WNT9A-FRZB | WNT9A_HUMAN - SFRP3_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 190 | WNT9A-SFRP1 | WNT9A_HUMAN - SFRP1_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 191 | WNT9A-SFRP2 | WNT9A_HUMAN - SFRP2_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 192 | WNT9A-SFRP4 | WNT9A_HUMAN - SFRP4_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 193 | WNT9A-SFRP5 | WNT9A_HUMAN - SFRP5_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 194 | WNT9B-CER1 | WNT9B_HUMAN - CER1_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 195 | WNT9B-FRZB | WNT9B_HUMAN - SFRP3_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 196 | WNT9B-SFRP1 | WNT9B_HUMAN - SFRP1_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 197 | WNT9B-SFRP2 | WNT9B_HUMAN - SFRP2_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 198 | WNT9B-SFRP4 | WNT9B_HUMAN - SFRP4_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
| 199 | WNT9B-SFRP5 | WNT9B_HUMAN - SFRP5_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |